Protagonist Therapeutics, Inc. (PTGX)
103.78
+0.11
(+0.11%)
USD |
NASDAQ |
Apr 02, 16:00
103.75
-0.03
(-0.03%)
After-Hours: 20:00
Protagonist Therapeutics Market Cap : 6.627B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 582.73B |
| AbbVie, Inc. | 358.64B |
| Insmed, Inc. | 34.50B |
| Madrigal Pharmaceuticals, Inc. | 12.96B |
| PTC Therapeutics, Inc. | 5.530B |
Market Cap Related Metrics
| PS Ratio | 143.37 |
| Price to Book Value | 10.77 |
| Price to Free Cash Flow | 117.64 |
| Price | 103.78 |
| Earnings Yield | -1.97% |